References
- Caprio S, Amiel S, Tamborlane WV, Gelfand RA, Sherwin RS. Defective free-fatty acid and oxidative glucose metabolism in IDDM during hypoglycemia. Influence of glycemic control. Diabetes 39, 134–141, 1990.
- Carlsson A, Sundkvist G, Groop L, Tuomi T. Insulin and glucagon secretion in patients with slowly progressing autoimmune diabetes (LADA). J Clin Endocrinol Metab 85, 76–80, 2000.10634367
- Emami A, Youssef JE, Rabasa-Lhoret R, Pineau J, Castle JR, Haidar A. Modeling glucagon action in patients with type 1 diabetes. IEEE J Biomed Health Inform 21, 1163–1171, 2017.
- Gutniak M, Grill V, Wiechel KL, Efendic S. Basal and meal-induced somatostatin-like immunoreactivity in healthy subjects and in IDDM and totally pancreatectomized patients. Effects of acute blood glucose normalization. Diabetes 36, 802–807, 1987.10.2337/diab.36.7.8022884157
- Kielgast U, Asmar M, Madsbad S, Holst JJ. Effect of glucagon-like peptide-1 on alpha- and beta-cell function in C-peptide-negative type 1 diabetic patients. J Clin Endocrinol Metab 95, 2492–2496, 2010.
- Kielgast U, Krarup T, Holst JJ, Madsbad S. Four weeks of treatment with liraglutide reduces insulin dose without loss of glycemic control in type 1 diabetic patients with and without residual beta-cell function. Diabetes Care 34, 1463–1468, 2011.
- Kugler AJ, Thiman ML. Efficacy and safety profile of once-weekly dulaglutide in type 2 diabetes: a report on the emerging new data. Diabetes Metab Syndr Obes 11, 187–197, 2018.
- Kutoh E, Hori T. Effect of sitagliptin in type 1 or type 2 diabetic patients with absolute insulin deficiency: A 48 weeks observational study. BrJ Med Med Res 3, 1910–1917, 2013.10.9734/BJMMR/2013/4295
- Sandoval DA, D’Alessio DA. Physiology of proglucagon peptides: role of glucagon and GLP-1 in health and disease. Physiol Rev 95, 513–548, 2015.
- Sherr J, Tsalikian E, Fox L, Buckingham B, Weinzimer S, Tamborlane WV, White NH, Arbelaez AM, Kollman C, Ruedy KJ, Cheng P, Beck RW; Diabetes Research in Children Network. Evolution of abnormal plasma glucagon responses to mixed-meal feedings in youth with type 1 diabetes during the first 2 years after diagnosis. Diabetes Care 37, 1741–1744, 2014.